This event provides the most relevant and topical details targeted at helping organizations enhance their pharmaceutical supply chain management and logistics practices, in addition to discuss the latest issues affecting the market going forward. Acsis, Inc. Offers been regarded time and because of its industry-leading source chain visibility solutions again. In addition to the recent reputation by LogiPharma, Acsis offers been named to the Source & Demand Chain Executive 100 list for just two consecutive years and Acsis clients have already been awarded the Managing Automation Progressive Production 100 Award for 2009 and 2010.. Acsis recognized as 2010 ‘Top Preferred Solution Provider’ by LogiPharma Acsis, Inc., a leader in supply chain visibility and traceability for manufacturing and distribution, today announced that it’s been recognized as a 2010 Best Preferred Solution Company by LogiPharma.AGH is one of simply three medical centers in the country accepted by the U.S. Drug and Meals Administration to investigate the efficacy of an oral fluorescent compound, known as 5-aminoevulnic acid , in a clinical trial of patients identified as having a glioma, the most typical form of primary human brain tumor. Gliomas strike an estimated 10-12 thousand people each full year in the usa and vary in severity. High grade gliomas, such as glioblastoma multiforma, are progressive and fatal malignant tumors rapidly.